Expected Moves

Q3 2026 earnings report. Investors will look for a rebound in operating margins and net income after the previous quarter's unexpected contraction to a net loss (-$0.0998 EPS). Focus will be on the resumption of healthcare IT budget deployments.

Key seasonal window for Japanese hospitals finalizing fiscal year IT and digital infrastructure budgets, directly dictating FINDEX's late-year software upgrade contracts and order pipeline.

Full-year fiscal 2026 earnings release and forward guidance. The critical print will dictate whether the recent top-line contraction (-1.58% YoY) is fully reversed by next-generation product deployments.

Anticipated rollout schedule and adoption metrics for their next-generation cloud-based clinical data management systems. A key driver for stabilizing recurring revenue.